Patient–physician communication and health‐related quality of life of patients with localised prostate cancer undergoing radical prostatectomy – a longitudinal multilevel analysis

Ernstmann, Nicole; Weißbach, L.; Herden, Jan; Winter, Nicola; Ansmann, Lena

doi:10.1111/bju.13495

Cited by 47 publications

(29 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While HRQoL outcomes have been well documented after diagnosis of prostate cancer, most research studies focus on impacts of different treatments or supportive interventions on HRQoL over time. Moreover, studies have examined HRQoL changes with repeated measurements long‐term after diagnosis of prostate cancer . However, to our knowledge, studies that examined physical and mental HRQoL changes in prostate cancer survivors have made assumptions that the whole study population can be represented by a single pattern of HRQoL, by measuring average changes in HRQoL.…”

Section: Introductionmentioning

confidence: 99%

Identification and prediction of health‐related quality of life trajectories after a prostate cancer diagnosis

Farris

Kopciuk

Courneya

et al. 2017

Intl Journal of Cancer

View full text Add to dashboard Cite

The aim of our study was to identify physical and mental health-related quality of life (HRQoL) trajectories after a prostate cancer diagnosis and systematically characterize trajectories by behaviours and prognostic factors. Prostate cancer survivors (n = 817) diagnosed between 1997 and 2000 were recruited between 2000 and 2002 into a prospective repeated measurements study. Behavioural/prognostic data were collected through in-person interviews and questionnaires. HRQoL was collected at three post-diagnosis time-points, approximately 2 years apart using the Short Form (SF)-36 validated questionnaire. To identify physical and mental HRQoL trajectories, group-based trajectory modelling was undertaken. Differences between groups were evaluated by assessing influential dropouts (mortality/poor health), behavioural/prognostic factors at diagnosis or during the follow-up. Three trajectories of physical HRQoL were identified including: average-maintaining HRQoL (32.2%), low-declining HRQoL (40.5%) and very low-maintaining HRQoL (27.3%). In addition, three trajectories for mental HRQoL were identified: average-increasing HRQoL (66.5%), above average-declining HRQoL (19.7%) and low-increasing HRQoL (13.8%). In both physical and mental HRQoL, dropout from mortality/poor health differed between trajectories, thus confirming HRQoL and mortality were related. Furthermore, increased Charlson comorbidity index score was consistently associated with physical and mental HRQoL group membership relative to average maintaining groups, while behaviours such as time-varying physical activity was associated with physical HRQoL trajectories but not mental HRQoL trajectories. It was possible to define three trajectories of physical and mental HRQoL after prostate cancer. These data provide insights regarding means for identifying subgroups of prostate cancer survivors with lower or declining HRQoL after diagnosis whom could be targeted for interventions aimed at improving HRQoL.

show abstract

Section: Introductionmentioning

confidence: 99%

Identification and prediction of health‐related quality of life trajectories after a prostate cancer diagnosis

Farris

Kopciuk

Courneya

et al. 2017

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…In EXTREQOL; men who had an overall better QoL at baseline reported receiving more information about their disease and treatment. These findings may reflect better doctor-patient communication, which is shown to have a strong influence on QoL [33].…”

Section: Discussionmentioning

confidence: 86%

Treatment Experiences, Information Needs, Pain and Quality of Life in Men with Metastatic Castrate-resistant Prostate Cancer: Results from the EXTREQOL Study

et al. 2019

View full text Add to dashboard Cite

Delaying progression, ameliorating symptoms and maintaining Quality of Life (QoL) are primary aims of treatment for metastatic Castrate Resistant Prostate Cancer (mCRPC). Real world rather than clinical trial data about symptoms and side effects are sparse. In EXTREQOL patients' QoL, pain and information needs were recorded during treatment. Methods Men with mCRPC from 20 UK cancer centres commencing various systemic mCRPC treatments completed QoL, pain and information needs questionnaires at baseline, 3 and 6 months. Results 132 patients were recruited. Overall QoL declined significantly by 6 months (Functional Assessment of Cancer Therapy-Prostate (FACT-P) mean=-3.89, 95% CI:-6.7 to-1.05, p =0.007; Trial Outcome Index analysis (TOI) mean=-3.10, 95% CI:-5.34 to-0.83, p = 0.007. Those who came off novel therapy and remained on LHRH agonist therapy alone had worse scores than patients receiving concomitant chemotherapy (Prostate Concerns Subscale (PSC) mean difference=-4.45, 95% CI: 95%

show abstract

“…Эти данные свидетельствуют о необходимости проведения реабилитационных мероприятий у этой категории больных, что согласуется с мнением ряда авторов [19,20]. С одной стороны, они связаны с оказанием психологической поддержки, а иногда и психиатрической помощи, и имеются публикации об эффективности этих мероприятий [21][22][23], а с другой -с мероприятиями по восстановлению возможности половой жизни. Из больных с развившейся после операции ЭД 34,2% хотели бы улучшить сексуальную функцию [6].…”

Section: обсуждение результатовunclassified

Rehabilitation Effect of Correction of Erectile Dysfunction in Patients Who Underwent Radical Prostatectomy for Prostate Cancer

Асратов¹,

Виноградов²,

Гвасалия³

et al. 2018

Issled. prakt. med. (Print)

View full text Add to dashboard Cite

show abstract

Patient–physician communication and health‐related quality of life of patients with localised prostate cancer undergoing radical prostatectomy – a longitudinal multilevel analysis

Cited by 47 publications

References 56 publications

Identification and prediction of health‐related quality of life trajectories after a prostate cancer diagnosis

Identification and prediction of health‐related quality of life trajectories after a prostate cancer diagnosis

Treatment Experiences, Information Needs, Pain and Quality of Life in Men with Metastatic Castrate-resistant Prostate Cancer: Results from the EXTREQOL Study

Rehabilitation Effect of Correction of Erectile Dysfunction in Patients Who Underwent Radical Prostatectomy for Prostate Cancer

Contact Info

Product

Resources

About